Seeing Is Believing

Currently out of the existing stock ratings of Jason Bednar, 277 are a BUY (75.07%), 84 are a HOLD (22.76%), 8 are a SELL (2.17%).
Analyst Jason Bednar, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 47.62% that have a potential upside of 31.63% achieved within 145 days.
Jason Bednar’s has documented 726 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ICUI, ICU Medical at 20-Feb-2026.
Analyst best performing recommendations are on VAPO (VAPOTHERM).
The best stock recommendation documented was for VAPO (VAPOTHERM) at 11/3/2022. The price target of $8 was fulfilled within 1 day with a profit of $2.08 (20.63%) receiving and performance score of 206.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Feb-2025
$200
$9.98 (5.25%)
$181
20 days ago
(05-Feb-2026)
1/5 (20%)
$24.38 (13.88%)
99
Buy Since 01-May-2025
$220
$29.98 (15.78%)
$200
20 days ago
(05-Feb-2026)
16/49 (32.65%)
$44.38 (25.27%)
101
Hold Since 27-Oct-2023
$185
$-5.02 (-2.64%)
$155
20 days ago
(05-Feb-2026)
12/19 (63.16%)
$9.38 (5.34%)
107
Buy Since 02-Feb-2023
$200
$9.98 (5.25%)
$170
20 days ago
(05-Feb-2026)
9/18 (50%)
$24.38 (13.88%)
190
Buy Since 18-Oct-2013
$210
$19.98 (10.51%)
$200
20 days ago
(05-Feb-2026)
29/47 (61.7%)
$34.38 (19.58%)
144
Which stock is Jason Bednar is most bullish on?
Which stock is Jason Bednar is most reserved on?
What Year was the first public recommendation made by Jason Bednar?